Chikungunya is a virus (CHIKV) spread by bites from infected mosquitoes. Outbreaks have occurred in most areas of the world, including the Americas, Asia, Africa, Europe, and islands in the Indian ...

The chikungunya virus spreads to humans through mosquito bites and contact with blood. It is rarely fatal, but the symptoms can be long-lasting. Learn more here.

Once limited to tropical and subtropical climates, the Aedes mosquitoes that transmit these diseases are spreading to new ...

Chikungunya which is reported from many parts of the country during the past few weeks is a viral disease transmitted to ...

Chikungunya, a mosquito-borne disease whose name in the Makonde dialect of Africa means “bending over in pain,” has no specific treatment and can be debilitating and even deadly for newborns ...

Chikungunya virus can be identified in the blood during the first week of illness. ... Treatment Options. There is presently a vaccine available for virus but it is costly.

Most people don't die from the virus. In fact, you'll probably recover in a few weeks. Acute symptoms usually end after 7 to 10 days. There can be long-term effects from getting the chikungunya virus.

As Chikungunya spreads into new regions, LJI scientists share a first look at how human T cells target the virus. Their ...

The FDA on Thursday announced approval of Ixchiq, the first chikungunya vaccine, for anyone 18 and older who has a risk of being exposed to the mosquito-borne virus.

The U.S. Food and Drug Administration on Thursday approved the first vaccine against chikungunya virus, a disease that is primarily transmitted to people through infected mosquito bites. The ...

A preliminary study has found that efavirenz — a non-nucleoside inhibitor of HIV virus that is used for treating HIV/AIDS — can be repurposed for the treatment of chikungunya.